Bundle: Utility of Cell-free DNA in the Clinic: Current State and Future Directions
CME and CMLE credits are not available for this course.
Welcome to the eight-part series on liquid biopsy titled, “Utility of Cell-free DNA in the Clinic: Current State and Future Directions.” This series covers a range of concepts from the basic biological underpinnings of cell-free DNA (cfDNA) to new and specific advances (and the clinical implications thereof) in the diagnostic and prognostic use of cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA). ch section of the program.
Learning Objectives:
Following the full program, participants will be able to:
- Describe the components of Cell-free DNA (cfDNA), and its dynamics in health and disease.
- Identify challenges, and list possible solutions, unique to cfDNA assay validation.
- Discuss opportunities of Circulating Tumor DNA (ctDNA) assessment in oncology practices.
- Discuss limitations of ctDNA assessment in oncology practices.
- Summarize current standards and practices in NIPS
- Recognize opportunities and pitfalls of non-invasive microbial assessment
- Describe the possible roles for novel circulating analytes in oncology.
- Discuss the unique advantages and disadvantages of alternate sources of cfDNA.
Webinars Included in the bundle
- Basic Biology and Detection of Cell-Free DNA
- Practical Analytical and Clinical validation Strategies for Cell-Free Tumor DNA Assays
- Opportunities and Challenges Toward the Clinical Application of ctDNA MRD Testing in Solid Cancers
- Current and Emerging Applications of cell-free DNA Tumor Tests
- Utility of Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Infections
- Cell free (cf)DNA-based Prenatal Screening: Lessons Learned and Future Strategies
- Cell-free DNA: predictive tissue injury maps in COVID-19
- Utility of Clinical Metagenomic Next-Generation Sequencing for Diagnosis of Infections
Duration: ~8.0 hours of video
Program Launched: April 14, 2023
Faculty
Continuing Education Credit
CME and CMLE credits are not available for this course.
Supported by an educational grant from AstraZeneca and by educational funding provided by Amgen.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation